Xlife Sciences AG
As a biologist with a doctorate in the field of immunology, Dr. Ludger Grosse-Hovest for more than 25 years with recombinant therapeutic antibodies for cancer treatment and also with the development of new antibody formats. Until 2012 he was a group leader at the Institute for Immunology at the Eberhard-Karls University in Tübingen. Building on an award and funding received from the German Federal Ministry of Education and Research (BMBF), he co-founded the biotechnology company Synimmune GmbH in 2012, in which he has been responsible for scientific management and management to this day.
This person is not in the org chart
This person is not in any offices
Xlife Sciences AG
Xlif Sciences provides researchers & entrepreneurs in developing & implementing their concepts and help it to reach the health care markets.